119 related articles for article (PubMed ID: 8906594)
21. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.
Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA
J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601
[TBL] [Abstract][Full Text] [Related]
23. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression.
Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC
Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855
[TBL] [Abstract][Full Text] [Related]
24. n-Docosanol inhibits in vitro replication of HIV and other retroviruses.
Marcelletti JF; Lusso P; Katz DH
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):71-4. PubMed ID: 8825621
[No Abstract] [Full Text] [Related]
25. Chain length specificity in the utilization of long chain alcohols for ether lipid biosynthesis in rat brain.
Natarajan V; Schmid HH
Lipids; 1977 Oct; 12(10):872-5. PubMed ID: 916829
[TBL] [Abstract][Full Text] [Related]
26. Anti-herpes simplex virus activity of alkaloids isolated from Stephania cepharantha.
Nawawi A; Ma C; Nakamura N; Hattori M; Kurokawa M; Shiraki K; Kashiwaba N; Ono M
Biol Pharm Bull; 1999 Mar; 22(3):268-74. PubMed ID: 10220283
[TBL] [Abstract][Full Text] [Related]
27. Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
Prescrire Int; 2009 Jun; 18(101):106-7. PubMed ID: 19637417
[TBL] [Abstract][Full Text] [Related]
28. Anti-Infectivity against Herpes Simplex Virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from
Brezáni V; Leláková V; Hassan STS; Berchová-Bímová K; Nový P; Klouček P; Maršík P; Dall'Acqua S; Hošek J; Šmejkal K
Viruses; 2018 Jul; 10(7):. PubMed ID: 29986399
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of fatty alcohol in MCF-7 breast cancer cells.
Welsh CJ; Robinson M; Warne TR; Pierce JH; Yeh GC; Phang JM
Arch Biochem Biophys; 1994 Nov; 315(1):41-7. PubMed ID: 7979403
[TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
Schnitzler P; Schön K; Reichling J
Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides.
Rahim SG; Trivedi N; Bogunovic-Batchelor MV; Hardy GW; Mills G; Selway JW; Snowden W; Littler E; Coe PL; Basnak I; Whale RF; Walker RT
J Med Chem; 1996 Feb; 39(3):789-95. PubMed ID: 8576922
[TBL] [Abstract][Full Text] [Related]
32. Methods for screening and profiling inhibitors of herpes simplex viruses.
Gong EY
Methods Mol Biol; 2013; 1030():303-13. PubMed ID: 23821277
[TBL] [Abstract][Full Text] [Related]
33. The comparative anti-herpes simplex virus effects of human interferons.
Taylor JL; Little SD; O'Brien WJ
J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977
[TBL] [Abstract][Full Text] [Related]
34. Different antiviral potencies of BV-araU and related nucleoside analogues against herpes simplex virus type 1 in human cell lines and Vero cells.
Machida H; Nishitani M; Suzutani T; Hayashi K
Microbiol Immunol; 1991; 35(11):963-73. PubMed ID: 1663576
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of biofilm and biofilm-associated virulence factor production in methicillin-resistant Staphylococcus aureus by docosanol.
Lakshmi SA; Bhaskar JP; Krishnan V; Sethupathy S; Pandipriya S; Aruni W; Pandian SK
J Biotechnol; 2020 Jun; 317():59-69. PubMed ID: 32353392
[TBL] [Abstract][Full Text] [Related]
36. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives.
Lowden CT; Bastow KF
Antiviral Res; 2003 Aug; 59(3):143-54. PubMed ID: 12927304
[TBL] [Abstract][Full Text] [Related]
37. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication.
Dargan DJ; Subak-Sharpe JH
J Gen Virol; 1985 Aug; 66 ( Pt 8)():1771-84. PubMed ID: 2991440
[TBL] [Abstract][Full Text] [Related]
38. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
[TBL] [Abstract][Full Text] [Related]
39. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice.
Docherty JJ; Smith JS; Fu MM; Stoner T; Booth T
Antiviral Res; 2004 Jan; 61(1):19-26. PubMed ID: 14670590
[TBL] [Abstract][Full Text] [Related]
40. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus].
Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS
Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
